Core Insights - InfuSystems Holdings, Inc. reported quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share, representing an earnings surprise of -50% [1] - The company posted revenues of $33.85 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 1.61%, compared to year-ago revenues of $31.77 million [2] - InfuSystems Holdings shares have declined approximately 14.1% since the beginning of the year, while the S&P 500 has decreased by -0.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.04 on revenues of $33.8 million, and for the current fiscal year, it is $0.31 on revenues of $146.6 million [7] - The estimate revisions trend for InfuSystems Holdings is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Products industry, to which InfuSystems Holdings belongs, is currently in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Ayr Wellness Inc., another company in the same industry, is expected to report a quarterly loss of $0.29 per share, reflecting a year-over-year change of +19.4% [9]
InfuSystems Holdings, Inc. (INFU) Misses Q4 Earnings and Revenue Estimates